@aga-gihn.bsky.social
Pinned
Our November issue is live! Don't miss our articles on:
⭐Member spotlight
⭐Physician payment gains and gaps
⭐Clinical implications of the new liver nomenclature
⭐Perspectives on AI in #GI and endoscopy
Read now: ow.ly/ErcI50Xnf0g
⭐Member spotlight
⭐Physician payment gains and gaps
⭐Clinical implications of the new liver nomenclature
⭐Perspectives on AI in #GI and endoscopy
Read now: ow.ly/ErcI50Xnf0g
Duvakitug, a novel anti-TL1a antibody, showed potential for adults with Crohn's disease, a study presented at #ACG2025 found. Learn more 👉
Novel Anti-TL1a Antibody Shows Potential for Crohn’s Disease | MDedge
Duvakitug, a novel anti-TL1a monoclonal antibody, demonstrated statistically significant differences in endoscopic response rates compared to placebo in adults
ow.ly
November 24, 2025 at 3:03 PM
Duvakitug, a novel anti-TL1a antibody, showed potential for adults with Crohn's disease, a study presented at #ACG2025 found. Learn more 👉
Pediatric Wilson’s disease 🔗linked to higher risk and worse outcomes compared with adults, according to a new study in @aga-ghadvances.bsky.social: ow.ly/lH9050XrUzs
November 20, 2025 at 3:02 PM
Pediatric Wilson’s disease 🔗linked to higher risk and worse outcomes compared with adults, according to a new study in @aga-ghadvances.bsky.social: ow.ly/lH9050XrUzs
“Patients often raise questions about colonics or detox teas, especially when these gain traction on social media platforms like TikTok." — Tauseef Ali, MD, AGAF
How should GIs approach this conversation about colon cleanses? We spoke to @bilalmohammadmd.bsky.social and more: ow.ly/Vsih50XnUNu
How should GIs approach this conversation about colon cleanses? We spoke to @bilalmohammadmd.bsky.social and more: ow.ly/Vsih50XnUNu
November 17, 2025 at 4:03 PM
“Patients often raise questions about colonics or detox teas, especially when these gain traction on social media platforms like TikTok." — Tauseef Ali, MD, AGAF
How should GIs approach this conversation about colon cleanses? We spoke to @bilalmohammadmd.bsky.social and more: ow.ly/Vsih50XnUNu
How should GIs approach this conversation about colon cleanses? We spoke to @bilalmohammadmd.bsky.social and more: ow.ly/Vsih50XnUNu
In this month's Perspectives column, we explore how AI is reshaping clinical care — while also emphasizing the need for caution, thoughtful integration, and ongoing oversight.
AI in Gastroenterology and Endoscopy | MDedge
In this issue of Perspectives, we present two timely essays that explore how AI is reshaping clinical care—while also emphasizing the need for caution, thoughtf
ow.ly
November 14, 2025 at 1:01 PM
In this month's Perspectives column, we explore how AI is reshaping clinical care — while also emphasizing the need for caution, thoughtful integration, and ongoing oversight.
Dr. Manol Jovani is our November member spotlight! In an interview, Dr. Jovani discusses third space endoscopy, his advice for aspiring med students, and where he sees the #GI field going in the next 5 years.
👉https://ow.ly/6G7n50Xnfbk
👉https://ow.ly/6G7n50Xnfbk
November 11, 2025 at 3:04 PM
Dr. Manol Jovani is our November member spotlight! In an interview, Dr. Jovani discusses third space endoscopy, his advice for aspiring med students, and where he sees the #GI field going in the next 5 years.
👉https://ow.ly/6G7n50Xnfbk
👉https://ow.ly/6G7n50Xnfbk
This study published in @AmJGastro found that cold snare usage for removing small polyps was lower than expected for U.S. endoscopists, despite being the recommended method. ow.ly/7bH550XnVlM
November 7, 2025 at 1:02 PM
This study published in @AmJGastro found that cold snare usage for removing small polyps was lower than expected for U.S. endoscopists, despite being the recommended method. ow.ly/7bH550XnVlM
Our November issue is live! Don't miss our articles on:
⭐Member spotlight
⭐Physician payment gains and gaps
⭐Clinical implications of the new liver nomenclature
⭐Perspectives on AI in #GI and endoscopy
Read now: ow.ly/ErcI50Xnf0g
⭐Member spotlight
⭐Physician payment gains and gaps
⭐Clinical implications of the new liver nomenclature
⭐Perspectives on AI in #GI and endoscopy
Read now: ow.ly/ErcI50Xnf0g
November 5, 2025 at 6:00 PM
Our November issue is live! Don't miss our articles on:
⭐Member spotlight
⭐Physician payment gains and gaps
⭐Clinical implications of the new liver nomenclature
⭐Perspectives on AI in #GI and endoscopy
Read now: ow.ly/ErcI50Xnf0g
⭐Member spotlight
⭐Physician payment gains and gaps
⭐Clinical implications of the new liver nomenclature
⭐Perspectives on AI in #GI and endoscopy
Read now: ow.ly/ErcI50Xnf0g
The @fda.gov expands Rinvoq's use for #IBD: Now approved for adults with moderate-to-severe #UC or Crohn’s who’ve tried ≥1 systemic therapy — no need to fail a TNF blocker first. www.mdedge.com/gihepnews/ar...
October 31, 2025 at 4:05 PM
The @fda.gov expands Rinvoq's use for #IBD: Now approved for adults with moderate-to-severe #UC or Crohn’s who’ve tried ≥1 systemic therapy — no need to fail a TNF blocker first. www.mdedge.com/gihepnews/ar...
🆕 study in BMJ Public Health finds less than half of adults who start #CRC screening with an at-home stool test completed the recommended repeat test, But “the best CRC screening test is the one that gets done,” said author Dr. Staci J. Wendt.
Half of Patients Skip Repeat Stool Tests for CRC Screening | MDedge
fewer than half of adults who started colorectal cancer (CRC) screening with an at-home stool test completed the recommended repeat test, creating gaps in prote
ow.ly
October 29, 2025 at 3:07 PM
🆕 study in BMJ Public Health finds less than half of adults who start #CRC screening with an at-home stool test completed the recommended repeat test, But “the best CRC screening test is the one that gets done,” said author Dr. Staci J. Wendt.
From @aga-cgh.bsky.social: anti-TNF antagonists may weaken the benefit of some advanced therapies for #UC, while enhancing the efficacy of others.
Anti-TNF Exposure Influences Efficacy of Subsequent Therapies in UC | MDedge
Prior exposure to tumor necrosis factor (TNF) antagonists may weaken the benefit of some advanced therapies for ulcerative colitis (UC) while enhancing the effi
ow.ly
October 27, 2025 at 2:06 PM
From @aga-cgh.bsky.social: anti-TNF antagonists may weaken the benefit of some advanced therapies for #UC, while enhancing the efficacy of others.
From #UEGWeek: Dr. Maria Effenberg highlighted clinical implications of the new liver disease nomenclature and discussed pros and cons. @myueg.bsky.social ow.ly/wb9Q50XbQNx
October 23, 2025 at 1:04 PM
From #UEGWeek: Dr. Maria Effenberg highlighted clinical implications of the new liver disease nomenclature and discussed pros and cons. @myueg.bsky.social ow.ly/wb9Q50XbQNx
Is #AI causing endoscopists to lose their skills? We spoke to lead authors from the study published in @lancetgastrohep.bsky.social.
➡️
➡️
Is AI Use Causing Endoscopists to Lose Their Skills? | MDedge
Routine use of artificial intelligence (AI) may lead to a loss of skills among clinicians who perform colonoscopies, thereby affecting patient outcomes
ow.ly
October 22, 2025 at 12:06 PM
Is #AI causing endoscopists to lose their skills? We spoke to lead authors from the study published in @lancetgastrohep.bsky.social.
➡️
➡️
Our October member spotlight is Dr. Pascale M. White! Dr. White discusses her mission to connect with communities to improve screening rates for colorectal cancer, her position as co-founder of ABGH, and more in our interview: ow.ly/Ay8N50XbRwb
October 21, 2025 at 5:00 PM
Our October member spotlight is Dr. Pascale M. White! Dr. White discusses her mission to connect with communities to improve screening rates for colorectal cancer, her position as co-founder of ABGH, and more in our interview: ow.ly/Ay8N50XbRwb
🎃 Have you read our October issue yet? This month, we summarize global guidelines for pregnancy and #IBD, provide an update on the FDA approval of semaglutide for MASH with fibrosis, and highlight member spotlight Dr. Pascale M. White.
📰 Read now: ow.ly/UxnR50XbQxv
📰 Read now: ow.ly/UxnR50XbQxv
October 15, 2025 at 3:50 PM
🎃 Have you read our October issue yet? This month, we summarize global guidelines for pregnancy and #IBD, provide an update on the FDA approval of semaglutide for MASH with fibrosis, and highlight member spotlight Dr. Pascale M. White.
📰 Read now: ow.ly/UxnR50XbQxv
📰 Read now: ow.ly/UxnR50XbQxv
In this video from The New Gastroenterologist and DHPA, Dr. Peter Naas shares advice for young GIs starting a career in private practice gastroenterology. 🎥 Watch now: ow.ly/NSlx50WNKMj
October 1, 2025 at 12:56 PM
In this video from The New Gastroenterologist and DHPA, Dr. Peter Naas shares advice for young GIs starting a career in private practice gastroenterology. 🎥 Watch now: ow.ly/NSlx50WNKMj
To be an effective #GI consultant, Dr. Allon Kahn advises being the following 5️⃣ things: kind, timely, specific, helpful and honest.
Read more of his tips for The New Gastroenterologist: ow.ly/eEPa50WNKKV
Read more of his tips for The New Gastroenterologist: ow.ly/eEPa50WNKKV
September 25, 2025 at 2:03 PM
To be an effective #GI consultant, Dr. Allon Kahn advises being the following 5️⃣ things: kind, timely, specific, helpful and honest.
Read more of his tips for The New Gastroenterologist: ow.ly/eEPa50WNKKV
Read more of his tips for The New Gastroenterologist: ow.ly/eEPa50WNKKV
More than 10% of GIs may face a malpractice claim, but it’s rarely discussed in med school. For The New Gastroenterologist, Dr. Koushik Das explains what malpractice is, the timeline of a lawsuit, and other consequences you might need to know. 👉 ow.ly/YaO950WNKJh
September 22, 2025 at 1:06 PM
More than 10% of GIs may face a malpractice claim, but it’s rarely discussed in med school. For The New Gastroenterologist, Dr. Koushik Das explains what malpractice is, the timeline of a lawsuit, and other consequences you might need to know. 👉 ow.ly/YaO950WNKJh
In this month's Perspectives column, Dr. Anahita Rabiee and Dr. Tarek Sawa discuss approaches to esophageal varices and Barrett’s esophagus, highlighting shifts in screening, surveillance, & innovation in GI care.
🔗 Read more: ow.ly/gMiq50WRtGz
🔗 Read more: ow.ly/gMiq50WRtGz
September 19, 2025 at 12:03 PM
In this month's Perspectives column, Dr. Anahita Rabiee and Dr. Tarek Sawa discuss approaches to esophageal varices and Barrett’s esophagus, highlighting shifts in screening, surveillance, & innovation in GI care.
🔗 Read more: ow.ly/gMiq50WRtGz
🔗 Read more: ow.ly/gMiq50WRtGz
#GLP1 has become a cornerstone in diabetes in weight loss management. For The New Gastroenterologist, Dr. Nikiya Asamoah & Dr. Sitharthan Sekar review current evidence and guidelines for GLP-1 use for endoscopic procedures ➡️ ow.ly/nZet50WNKHC
September 17, 2025 at 8:02 PM
#GLP1 has become a cornerstone in diabetes in weight loss management. For The New Gastroenterologist, Dr. Nikiya Asamoah & Dr. Sitharthan Sekar review current evidence and guidelines for GLP-1 use for endoscopic procedures ➡️ ow.ly/nZet50WNKHC
Exocrine pancreatic insufficiency is a challenging diagnosis. In this month’s In Focus, review how to approach diagnosing and treating EPI, plus screening for complications. www.mdedge.com/gihepnews/ar...
September 16, 2025 at 4:04 PM
Exocrine pancreatic insufficiency is a challenging diagnosis. In this month’s In Focus, review how to approach diagnosing and treating EPI, plus screening for complications. www.mdedge.com/gihepnews/ar...
The latest issue of The New Gastroenterologist is live! In this issue, we cover exocrine pancreatic insufficiency, GLP-1 use, medical malpractice lawsuits and more. ow.ly/40bJ50WNKEQ
September 11, 2025 at 2:05 PM
The latest issue of The New Gastroenterologist is live! In this issue, we cover exocrine pancreatic insufficiency, GLP-1 use, medical malpractice lawsuits and more. ow.ly/40bJ50WNKEQ
🖤 Ready to be inspired and uplifted? #ABGHNexus2025 is bringing together Black women in medicine for an unforgettable experience Oct. 3–5 at The Times Center, NYC! Join ABGH for connection, growth, and empowerment—register by Sept. 19 to save! #BlackWomenInMedicine whova.com/portal/regis...
September 10, 2025 at 9:54 PM
🖤 Ready to be inspired and uplifted? #ABGHNexus2025 is bringing together Black women in medicine for an unforgettable experience Oct. 3–5 at The Times Center, NYC! Join ABGH for connection, growth, and empowerment—register by Sept. 19 to save! #BlackWomenInMedicine whova.com/portal/regis...
Our September member spotlight is @jessicakormanmd.bsky.social, whose mission is to reduce the stigma around anal cancer.
“I think GIs are uniquely positioned to help with diagnosing anal diseases. It is part of the digestive tract." Read ➡️ ow.ly/GGlw50WQCqc
“I think GIs are uniquely positioned to help with diagnosing anal diseases. It is part of the digestive tract." Read ➡️ ow.ly/GGlw50WQCqc
September 10, 2025 at 1:03 PM
Our September member spotlight is @jessicakormanmd.bsky.social, whose mission is to reduce the stigma around anal cancer.
“I think GIs are uniquely positioned to help with diagnosing anal diseases. It is part of the digestive tract." Read ➡️ ow.ly/GGlw50WQCqc
“I think GIs are uniquely positioned to help with diagnosing anal diseases. It is part of the digestive tract." Read ➡️ ow.ly/GGlw50WQCqc
New #IBS in America survey reveals that IBS symptoms continue to disrupt lives — an average of 19 days each month. ow.ly/5Ij650WOeEK
September 8, 2025 at 12:56 PM
New #IBS in America survey reveals that IBS symptoms continue to disrupt lives — an average of 19 days each month. ow.ly/5Ij650WOeEK
The @fda.gov has approved @novonordisk.bsky.social's Wegovy for treating MASH in adults with fibrosis but without cirrhosis. Learn more: www.mdedge.com/gihepnews/ar...
Wegovy Approved for MASH With Fibrosis, No Cirrhosis | MDedge
The FDA has granted accelerated approval to Novo Nordisk’s Wegovy for the treatment of metabolic-associated steatohepatitis (MASH) in adults with moderate-to-ad
ow.ly
September 5, 2025 at 3:03 PM
The @fda.gov has approved @novonordisk.bsky.social's Wegovy for treating MASH in adults with fibrosis but without cirrhosis. Learn more: www.mdedge.com/gihepnews/ar...